Advertisement

Index by author

February 01, 1992; Volume 41,Issue 2

A

  1. Allan, P W

    1. Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virus.
      W B Parker, S C Shaddix, P W Allan, G Arnett, L M Rose, W M Shannon, Y F Shealy, J A Montgomery, J A Secrist and L L Bennett
      Molecular Pharmacology February 1992, 41 (2) 245-251;

  2. Arnett, G

    1. Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virus.
      W B Parker, S C Shaddix, P W Allan, G Arnett, L M Rose, W M Shannon, Y F Shealy, J A Montgomery, J A Secrist and L L Bennett
      Molecular Pharmacology February 1992, 41 (2) 245-251;

B

  1. Bennett, L L

    1. Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virus.
      W B Parker, S C Shaddix, P W Allan, G Arnett, L M Rose, W M Shannon, Y F Shealy, J A Montgomery, J A Secrist and L L Bennett
      Molecular Pharmacology February 1992, 41 (2) 245-251;

  2. Berman, H A

    1. Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase.
      H A Berman and K Leonard
      Molecular Pharmacology February 1992, 41 (2) 412-418;

  3. Bielawska, A E

    1. Quantitative analysis of diacylglycerol second messengers in human platelets: correlation with aggregation and secretion.
      M H Werner, A E Bielawska and Y A Hannun
      Molecular Pharmacology February 1992, 41 (2) 382-386;

  4. Bijsterbosch, M K

    1. Lactosylated high density lipoprotein: a potential carrier for the site-specific delivery of drugs to parenchymal liver cells.
      M K Bijsterbosch and T J Van Berkel
      Molecular Pharmacology February 1992, 41 (2) 404-411;

  5. Bobichon, C

    1. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
      J C Randle, T Guet, C Bobichon, C Moreau, P Curutchet, B Lambolez, L P de Carvalho, A Cordi and J M Lepagnol
      Molecular Pharmacology February 1992, 41 (2) 337-345;

  6. Bockaert, J

    1. Specific antibodies against Go isoforms reveal the early expression of the Go2 alpha subunit and appearance of Go1 alpha during neuronal differentiation.
      B Rouot, N Charpentier, C Chabbert, J Carrette, R Zumbihl, J Bockaert and V Homburger
      Molecular Pharmacology February 1992, 41 (2) 273-280;
    2. Serotonin increases calcium current in human atrial myocytes via the newly described 5-hydroxytryptamine4 receptors.
      H Ouadid, J Seguin, A Dumuis, J Bockaert and J Nargeot
      Molecular Pharmacology February 1992, 41 (2) 346-351;

  7. Brann, M R

    1. Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors.
      J Wess, D Gdula and M R Brann
      Molecular Pharmacology February 1992, 41 (2) 369-374;

  8. Bridges, E G

    1. Comparative effects of 3'-azido-3'-deoxythymidine and its metabolite 3'-amino-3'-deoxythymidine on hemoglobin synthesis in K-562 human leukemia cells.
      D A Weidner, E G Bridges, E M Cretton and J P Sommadossi
      Molecular Pharmacology February 1992, 41 (2) 252-258;

  9. Brown, L M

    1. Stimulation of N-methyl-D-aspartate receptor-mediated calcium entry into dissociated neurons by reduced and oxidized glutathione.
      S W Leslie, L M Brown, R D Trent, Y H Lee, J L Morris, T W Jones, P K Randall, S S Lau and T J Monks
      Molecular Pharmacology February 1992, 41 (2) 308-314;

C

  1. Carrette, J

    1. Specific antibodies against Go isoforms reveal the early expression of the Go2 alpha subunit and appearance of Go1 alpha during neuronal differentiation.
      B Rouot, N Charpentier, C Chabbert, J Carrette, R Zumbihl, J Bockaert and V Homburger
      Molecular Pharmacology February 1992, 41 (2) 273-280;

  2. Chabbert, C

    1. Specific antibodies against Go isoforms reveal the early expression of the Go2 alpha subunit and appearance of Go1 alpha during neuronal differentiation.
      B Rouot, N Charpentier, C Chabbert, J Carrette, R Zumbihl, J Bockaert and V Homburger
      Molecular Pharmacology February 1992, 41 (2) 273-280;

  3. Charleson, P

    1. 5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors.
      J A Mancini, P Prasit, M G Coppolino, P Charleson, S Leger, J F Evans, J W Gillard and P J Vickers
      Molecular Pharmacology February 1992, 41 (2) 267-272;

  4. Charpentier, N

    1. Specific antibodies against Go isoforms reveal the early expression of the Go2 alpha subunit and appearance of Go1 alpha during neuronal differentiation.
      B Rouot, N Charpentier, C Chabbert, J Carrette, R Zumbihl, J Bockaert and V Homburger
      Molecular Pharmacology February 1992, 41 (2) 273-280;

  5. Chen, L I

    1. Topoisomerase II-mediated DNA cleavage activity and irreversibility of cleavable complex formation induced by DNA intercalator with alkylating capability.
      X B Kong, L Rubin, L I Chen, G Ciszewska, K A Watanabe, W P Tong, F M Sirotnak and T C Chou
      Molecular Pharmacology February 1992, 41 (2) 237-244;

  6. Cheng, Y C

    1. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
      W Y Gao, F S Han, C Storm, W Egan and Y C Cheng
      Molecular Pharmacology February 1992, 41 (2) 223-229;

  7. Chou, T C

    1. Topoisomerase II-mediated DNA cleavage activity and irreversibility of cleavable complex formation induced by DNA intercalator with alkylating capability.
      X B Kong, L Rubin, L I Chen, G Ciszewska, K A Watanabe, W P Tong, F M Sirotnak and T C Chou
      Molecular Pharmacology February 1992, 41 (2) 237-244;

  8. Ciszewska, G

    1. Topoisomerase II-mediated DNA cleavage activity and irreversibility of cleavable complex formation induced by DNA intercalator with alkylating capability.
      X B Kong, L Rubin, L I Chen, G Ciszewska, K A Watanabe, W P Tong, F M Sirotnak and T C Chou
      Molecular Pharmacology February 1992, 41 (2) 237-244;

  9. Clarke, S D

    1. Enhancement of adipocyte differentiation by an insulin-sensitizing agent.
      R F Kletzien, S D Clarke and R G Ulrich
      Molecular Pharmacology February 1992, 41 (2) 393-398;

  10. Coon, M J

    1. Role of isozymes of rabbit microsomal cytochrome P-450 in the metabolism of retinoic acid, retinol, and retinal.
      E S Roberts, A D Vaz and M J Coon
      Molecular Pharmacology February 1992, 41 (2) 427-433;

  11. Coppolino, M G

    1. 5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors.
      J A Mancini, P Prasit, M G Coppolino, P Charleson, S Leger, J F Evans, J W Gillard and P J Vickers
      Molecular Pharmacology February 1992, 41 (2) 267-272;

  12. Cordi, A

    1. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
      J C Randle, T Guet, C Bobichon, C Moreau, P Curutchet, B Lambolez, L P de Carvalho, A Cordi and J M Lepagnol
      Molecular Pharmacology February 1992, 41 (2) 337-345;

  13. Cowan, K H

    1. Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents.
      A J Townsend, C P Tu and K H Cowan
      Molecular Pharmacology February 1992, 41 (2) 230-236;

  14. Cretton, E M

    1. Comparative effects of 3'-azido-3'-deoxythymidine and its metabolite 3'-amino-3'-deoxythymidine on hemoglobin synthesis in K-562 human leukemia cells.
      D A Weidner, E G Bridges, E M Cretton and J P Sommadossi
      Molecular Pharmacology February 1992, 41 (2) 252-258;

  15. Curutchet, P

    1. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
      J C Randle, T Guet, C Bobichon, C Moreau, P Curutchet, B Lambolez, L P de Carvalho, A Cordi and J M Lepagnol
      Molecular Pharmacology February 1992, 41 (2) 337-345;

D

  1. D'Orleans-Juste, P

    1. Characterization of endothelin-converting enzyme from endothelial cells and rat brain: detection of the formation of biologically active endothelin-1 by rapid bioassay.
      T D Warner, J A Mitchell, P D'Orleans-Juste, K Ishii, U Förstermann and F Murad
      Molecular Pharmacology February 1992, 41 (2) 399-403;

  2. Daly, J W

    1. A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.
      I Hide, W L Padgett, K A Jacobson and J W Daly
      Molecular Pharmacology February 1992, 41 (2) 352-359;

  3. de Carvalho, L P

    1. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
      J C Randle, T Guet, C Bobichon, C Moreau, P Curutchet, B Lambolez, L P de Carvalho, A Cordi and J M Lepagnol
      Molecular Pharmacology February 1992, 41 (2) 337-345;

  4. Dumuis, A

    1. Serotonin increases calcium current in human atrial myocytes via the newly described 5-hydroxytryptamine4 receptors.
      H Ouadid, J Seguin, A Dumuis, J Bockaert and J Nargeot
      Molecular Pharmacology February 1992, 41 (2) 346-351;

  5. Duvvuri, P

    1. Modulation of phencyclidine-sensitive ethidium binding to the Torpedo acetylcholine receptor: interaction of noncompetitive inhibitors with carbamylcholine and cobra alpha-toxin.
      C F Valenzuela, J A Kerr, P Duvvuri and D A Johnson
      Molecular Pharmacology February 1992, 41 (2) 331-336;

E

  1. Egan, W

    1. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
      W Y Gao, F S Han, C Storm, W Egan and Y C Cheng
      Molecular Pharmacology February 1992, 41 (2) 223-229;

  2. Evans, J F

    1. 5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors.
      J A Mancini, P Prasit, M G Coppolino, P Charleson, S Leger, J F Evans, J W Gillard and P J Vickers
      Molecular Pharmacology February 1992, 41 (2) 267-272;

F

  1. Feuerstein, G

    1. Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C.
      T L Yue, J M Stadel, H M Sarau, E Friedman, J L Gu, D A Powers, M M Gleason, G Feuerstein and H Y Wang
      Molecular Pharmacology February 1992, 41 (2) 281-289;

  2. Förstermann, U

    1. Characterization of endothelin-converting enzyme from endothelial cells and rat brain: detection of the formation of biologically active endothelin-1 by rapid bioassay.
      T D Warner, J A Mitchell, P D'Orleans-Juste, K Ishii, U Förstermann and F Murad
      Molecular Pharmacology February 1992, 41 (2) 399-403;

  3. Friedman, E

    1. Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C.
      T L Yue, J M Stadel, H M Sarau, E Friedman, J L Gu, D A Powers, M M Gleason, G Feuerstein and H Y Wang
      Molecular Pharmacology February 1992, 41 (2) 281-289;

G

  1. Gao, W Y

    1. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
      W Y Gao, F S Han, C Storm, W Egan and Y C Cheng
      Molecular Pharmacology February 1992, 41 (2) 223-229;

  2. Gdula, D

    1. Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors.
      J Wess, D Gdula and M R Brann
      Molecular Pharmacology February 1992, 41 (2) 369-374;

  3. Gescher, A

    1. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
      R Hyland, A Gescher, K Thummel, C Schiller, P Jheeta, K Mynett, A W Smith and J Mráz
      Molecular Pharmacology February 1992, 41 (2) 259-266;

  4. Gillard, J W

    1. 5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors.
      J A Mancini, P Prasit, M G Coppolino, P Charleson, S Leger, J F Evans, J W Gillard and P J Vickers
      Molecular Pharmacology February 1992, 41 (2) 267-272;

  5. Gleason, M M

    1. Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C.
      T L Yue, J M Stadel, H M Sarau, E Friedman, J L Gu, D A Powers, M M Gleason, G Feuerstein and H Y Wang
      Molecular Pharmacology February 1992, 41 (2) 281-289;

  6. Glossmann, H

    1. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties.
      H G Knaus, J Striessnig, S Hering, S Marrer, E Schwenner, H D Höltje and H Glossmann
      Molecular Pharmacology February 1992, 41 (2) 298-307;

  7. Gu, J L

    1. Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C.
      T L Yue, J M Stadel, H M Sarau, E Friedman, J L Gu, D A Powers, M M Gleason, G Feuerstein and H Y Wang
      Molecular Pharmacology February 1992, 41 (2) 281-289;

  8. Guet, T

    1. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
      J C Randle, T Guet, C Bobichon, C Moreau, P Curutchet, B Lambolez, L P de Carvalho, A Cordi and J M Lepagnol
      Molecular Pharmacology February 1992, 41 (2) 337-345;

H

  1. Han, F S

    1. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
      W Y Gao, F S Han, C Storm, W Egan and Y C Cheng
      Molecular Pharmacology February 1992, 41 (2) 223-229;

  2. Hannun, Y A

    1. Quantitative analysis of diacylglycerol second messengers in human platelets: correlation with aggregation and secretion.
      M H Werner, A E Bielawska and Y A Hannun
      Molecular Pharmacology February 1992, 41 (2) 382-386;

  3. Hering, S

    1. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties.
      H G Knaus, J Striessnig, S Hering, S Marrer, E Schwenner, H D Höltje and H Glossmann
      Molecular Pharmacology February 1992, 41 (2) 298-307;

  4. Hide, I

    1. A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.
      I Hide, W L Padgett, K A Jacobson and J W Daly
      Molecular Pharmacology February 1992, 41 (2) 352-359;

  5. Höltje, H D

    1. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties.
      H G Knaus, J Striessnig, S Hering, S Marrer, E Schwenner, H D Höltje and H Glossmann
      Molecular Pharmacology February 1992, 41 (2) 298-307;

  6. Homburger, V

    1. Specific antibodies against Go isoforms reveal the early expression of the Go2 alpha subunit and appearance of Go1 alpha during neuronal differentiation.
      B Rouot, N Charpentier, C Chabbert, J Carrette, R Zumbihl, J Bockaert and V Homburger
      Molecular Pharmacology February 1992, 41 (2) 273-280;

  7. Hyland, R

    1. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
      R Hyland, A Gescher, K Thummel, C Schiller, P Jheeta, K Mynett, A W Smith and J Mráz
      Molecular Pharmacology February 1992, 41 (2) 259-266;

I

  1. Ishii, K

    1. Characterization of endothelin-converting enzyme from endothelial cells and rat brain: detection of the formation of biologically active endothelin-1 by rapid bioassay.
      T D Warner, J A Mitchell, P D'Orleans-Juste, K Ishii, U Förstermann and F Murad
      Molecular Pharmacology February 1992, 41 (2) 399-403;

J

  1. Jacobson, K A

    1. A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.
      I Hide, W L Padgett, K A Jacobson and J W Daly
      Molecular Pharmacology February 1992, 41 (2) 352-359;

  2. Jheeta, P

    1. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
      R Hyland, A Gescher, K Thummel, C Schiller, P Jheeta, K Mynett, A W Smith and J Mráz
      Molecular Pharmacology February 1992, 41 (2) 259-266;

  3. Johnson, D A

    1. Modulation of phencyclidine-sensitive ethidium binding to the Torpedo acetylcholine receptor: interaction of noncompetitive inhibitors with carbamylcholine and cobra alpha-toxin.
      C F Valenzuela, J A Kerr, P Duvvuri and D A Johnson
      Molecular Pharmacology February 1992, 41 (2) 331-336;

  4. Jones, T W

    1. Stimulation of N-methyl-D-aspartate receptor-mediated calcium entry into dissociated neurons by reduced and oxidized glutathione.
      S W Leslie, L M Brown, R D Trent, Y H Lee, J L Morris, T W Jones, P K Randall, S S Lau and T J Monks
      Molecular Pharmacology February 1992, 41 (2) 308-314;

K

  1. Kerr, J A

    1. Modulation of phencyclidine-sensitive ethidium binding to the Torpedo acetylcholine receptor: interaction of noncompetitive inhibitors with carbamylcholine and cobra alpha-toxin.
      C F Valenzuela, J A Kerr, P Duvvuri and D A Johnson
      Molecular Pharmacology February 1992, 41 (2) 331-336;

  2. Kletzien, R F

    1. Enhancement of adipocyte differentiation by an insulin-sensitizing agent.
      R F Kletzien, S D Clarke and R G Ulrich
      Molecular Pharmacology February 1992, 41 (2) 393-398;

  3. Knaus, H G

    1. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties.
      H G Knaus, J Striessnig, S Hering, S Marrer, E Schwenner, H D Höltje and H Glossmann
      Molecular Pharmacology February 1992, 41 (2) 298-307;

  4. Knoth, K M

    1. Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel.
      J Snyders, K M Knoth, S L Roberds and M M Tamkun
      Molecular Pharmacology February 1992, 41 (2) 322-330;

  5. Kong, X B

    1. Topoisomerase II-mediated DNA cleavage activity and irreversibility of cleavable complex formation induced by DNA intercalator with alkylating capability.
      X B Kong, L Rubin, L I Chen, G Ciszewska, K A Watanabe, W P Tong, F M Sirotnak and T C Chou
      Molecular Pharmacology February 1992, 41 (2) 237-244;

  6. Kurz, J B

    1. Isoproterenol-initiated beta-adrenergic receptor diacytosis in cultured cells.
      J B Kurz and J P Perkins
      Molecular Pharmacology February 1992, 41 (2) 375-381;

L

  1. Lambolez, B

    1. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
      J C Randle, T Guet, C Bobichon, C Moreau, P Curutchet, B Lambolez, L P de Carvalho, A Cordi and J M Lepagnol
      Molecular Pharmacology February 1992, 41 (2) 337-345;

  2. Lau, S S

    1. Stimulation of N-methyl-D-aspartate receptor-mediated calcium entry into dissociated neurons by reduced and oxidized glutathione.
      S W Leslie, L M Brown, R D Trent, Y H Lee, J L Morris, T W Jones, P K Randall, S S Lau and T J Monks
      Molecular Pharmacology February 1992, 41 (2) 308-314;

  3. Laurenza, A

    1. Interaction of aminoalkylcarbamates of forskolin with adenylyl cyclase: synthesis of an iodinated derivative of forskolin with high affinity for adenylyl cyclase.
      A Laurenza, J D Robbins and K B Seamon
      Molecular Pharmacology February 1992, 41 (2) 360-368;

  4. Lee, Y H

    1. Stimulation of N-methyl-D-aspartate receptor-mediated calcium entry into dissociated neurons by reduced and oxidized glutathione.
      S W Leslie, L M Brown, R D Trent, Y H Lee, J L Morris, T W Jones, P K Randall, S S Lau and T J Monks
      Molecular Pharmacology February 1992, 41 (2) 308-314;

  5. Leger, S

    1. 5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors.
      J A Mancini, P Prasit, M G Coppolino, P Charleson, S Leger, J F Evans, J W Gillard and P J Vickers
      Molecular Pharmacology February 1992, 41 (2) 267-272;

  6. Leonard, K

    1. Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase.
      H A Berman and K Leonard
      Molecular Pharmacology February 1992, 41 (2) 412-418;

  7. Lepagnol, J M

    1. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
      J C Randle, T Guet, C Bobichon, C Moreau, P Curutchet, B Lambolez, L P de Carvalho, A Cordi and J M Lepagnol
      Molecular Pharmacology February 1992, 41 (2) 337-345;

  8. Lerma, J

    1. Chloride transport blockers prevent N-methyl-D-aspartate receptor-channel complex activation.
      J Lerma and R Martín del Río
      Molecular Pharmacology February 1992, 41 (2) 217-222;

  9. Leslie, S W

    1. Stimulation of N-methyl-D-aspartate receptor-mediated calcium entry into dissociated neurons by reduced and oxidized glutathione.
      S W Leslie, L M Brown, R D Trent, Y H Lee, J L Morris, T W Jones, P K Randall, S S Lau and T J Monks
      Molecular Pharmacology February 1992, 41 (2) 308-314;

M

  1. Mancini, J A

    1. 5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors.
      J A Mancini, P Prasit, M G Coppolino, P Charleson, S Leger, J F Evans, J W Gillard and P J Vickers
      Molecular Pharmacology February 1992, 41 (2) 267-272;

  2. Maren, T H

    1. Direct measurements of the rate constants of sulfonamides with carbonic anhydrase.
      T H Maren
      Molecular Pharmacology February 1992, 41 (2) 419-426;

  3. Marrer, S

    1. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties.
      H G Knaus, J Striessnig, S Hering, S Marrer, E Schwenner, H D Höltje and H Glossmann
      Molecular Pharmacology February 1992, 41 (2) 298-307;

  4. Martín del Río, R

    1. Chloride transport blockers prevent N-methyl-D-aspartate receptor-channel complex activation.
      J Lerma and R Martín del Río
      Molecular Pharmacology February 1992, 41 (2) 217-222;

  5. Mason, R P

    1. Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
      R P Mason, D M Moisey and L Shajenko
      Molecular Pharmacology February 1992, 41 (2) 315-321;

  6. Mitchell, J A

    1. Characterization of endothelin-converting enzyme from endothelial cells and rat brain: detection of the formation of biologically active endothelin-1 by rapid bioassay.
      T D Warner, J A Mitchell, P D'Orleans-Juste, K Ishii, U Förstermann and F Murad
      Molecular Pharmacology February 1992, 41 (2) 399-403;

  7. Moisey, D M

    1. Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
      R P Mason, D M Moisey and L Shajenko
      Molecular Pharmacology February 1992, 41 (2) 315-321;

  8. Monks, T J

    1. Stimulation of N-methyl-D-aspartate receptor-mediated calcium entry into dissociated neurons by reduced and oxidized glutathione.
      S W Leslie, L M Brown, R D Trent, Y H Lee, J L Morris, T W Jones, P K Randall, S S Lau and T J Monks
      Molecular Pharmacology February 1992, 41 (2) 308-314;

  9. Montgomery, J A

    1. Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virus.
      W B Parker, S C Shaddix, P W Allan, G Arnett, L M Rose, W M Shannon, Y F Shealy, J A Montgomery, J A Secrist and L L Bennett
      Molecular Pharmacology February 1992, 41 (2) 245-251;

  10. Moreau, C

    1. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
      J C Randle, T Guet, C Bobichon, C Moreau, P Curutchet, B Lambolez, L P de Carvalho, A Cordi and J M Lepagnol
      Molecular Pharmacology February 1992, 41 (2) 337-345;

  11. Morris, J L

    1. Stimulation of N-methyl-D-aspartate receptor-mediated calcium entry into dissociated neurons by reduced and oxidized glutathione.
      S W Leslie, L M Brown, R D Trent, Y H Lee, J L Morris, T W Jones, P K Randall, S S Lau and T J Monks
      Molecular Pharmacology February 1992, 41 (2) 308-314;

  12. Mráz, J

    1. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
      R Hyland, A Gescher, K Thummel, C Schiller, P Jheeta, K Mynett, A W Smith and J Mráz
      Molecular Pharmacology February 1992, 41 (2) 259-266;

  13. Murad, F

    1. Characterization of endothelin-converting enzyme from endothelial cells and rat brain: detection of the formation of biologically active endothelin-1 by rapid bioassay.
      T D Warner, J A Mitchell, P D'Orleans-Juste, K Ishii, U Förstermann and F Murad
      Molecular Pharmacology February 1992, 41 (2) 399-403;

  14. Mynett, K

    1. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
      R Hyland, A Gescher, K Thummel, C Schiller, P Jheeta, K Mynett, A W Smith and J Mráz
      Molecular Pharmacology February 1992, 41 (2) 259-266;

N

  1. Nargeot, J

    1. Serotonin increases calcium current in human atrial myocytes via the newly described 5-hydroxytryptamine4 receptors.
      H Ouadid, J Seguin, A Dumuis, J Bockaert and J Nargeot
      Molecular Pharmacology February 1992, 41 (2) 346-351;

O

  1. O'Brian, C A

    1. Kinetic analysis of protein kinase C inhibition by staurosporine: evidence that inhibition entails inhibitor binding at a conserved region of the catalytic domain but not competition with substrates.
      N E Ward and C A O'Brian
      Molecular Pharmacology February 1992, 41 (2) 387-392;

  2. Ouadid, H

    1. Serotonin increases calcium current in human atrial myocytes via the newly described 5-hydroxytryptamine4 receptors.
      H Ouadid, J Seguin, A Dumuis, J Bockaert and J Nargeot
      Molecular Pharmacology February 1992, 41 (2) 346-351;

P

  1. Padgett, W L

    1. A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.
      I Hide, W L Padgett, K A Jacobson and J W Daly
      Molecular Pharmacology February 1992, 41 (2) 352-359;

  2. Parker, W B

    1. Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virus.
      W B Parker, S C Shaddix, P W Allan, G Arnett, L M Rose, W M Shannon, Y F Shealy, J A Montgomery, J A Secrist and L L Bennett
      Molecular Pharmacology February 1992, 41 (2) 245-251;

  3. Perkins, J P

    1. Isoproterenol-initiated beta-adrenergic receptor diacytosis in cultured cells.
      J B Kurz and J P Perkins
      Molecular Pharmacology February 1992, 41 (2) 375-381;

  4. Powers, D A

    1. Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C.
      T L Yue, J M Stadel, H M Sarau, E Friedman, J L Gu, D A Powers, M M Gleason, G Feuerstein and H Y Wang
      Molecular Pharmacology February 1992, 41 (2) 281-289;

  5. Prasit, P

    1. 5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors.
      J A Mancini, P Prasit, M G Coppolino, P Charleson, S Leger, J F Evans, J W Gillard and P J Vickers
      Molecular Pharmacology February 1992, 41 (2) 267-272;

R

  1. Randall, P K

    1. Stimulation of N-methyl-D-aspartate receptor-mediated calcium entry into dissociated neurons by reduced and oxidized glutathione.
      S W Leslie, L M Brown, R D Trent, Y H Lee, J L Morris, T W Jones, P K Randall, S S Lau and T J Monks
      Molecular Pharmacology February 1992, 41 (2) 308-314;

  2. Randle, J C

    1. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
      J C Randle, T Guet, C Bobichon, C Moreau, P Curutchet, B Lambolez, L P de Carvalho, A Cordi and J M Lepagnol
      Molecular Pharmacology February 1992, 41 (2) 337-345;

  3. Robbins, J D

    1. Interaction of aminoalkylcarbamates of forskolin with adenylyl cyclase: synthesis of an iodinated derivative of forskolin with high affinity for adenylyl cyclase.
      A Laurenza, J D Robbins and K B Seamon
      Molecular Pharmacology February 1992, 41 (2) 360-368;

  4. Roberds, S L

    1. Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel.
      J Snyders, K M Knoth, S L Roberds and M M Tamkun
      Molecular Pharmacology February 1992, 41 (2) 322-330;

  5. Roberts, E S

    1. Role of isozymes of rabbit microsomal cytochrome P-450 in the metabolism of retinoic acid, retinol, and retinal.
      E S Roberts, A D Vaz and M J Coon
      Molecular Pharmacology February 1992, 41 (2) 427-433;

  6. Rose, L M

    1. Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virus.
      W B Parker, S C Shaddix, P W Allan, G Arnett, L M Rose, W M Shannon, Y F Shealy, J A Montgomery, J A Secrist and L L Bennett
      Molecular Pharmacology February 1992, 41 (2) 245-251;

  7. Rouot, B

    1. Specific antibodies against Go isoforms reveal the early expression of the Go2 alpha subunit and appearance of Go1 alpha during neuronal differentiation.
      B Rouot, N Charpentier, C Chabbert, J Carrette, R Zumbihl, J Bockaert and V Homburger
      Molecular Pharmacology February 1992, 41 (2) 273-280;

  8. Rubin, L

    1. Topoisomerase II-mediated DNA cleavage activity and irreversibility of cleavable complex formation induced by DNA intercalator with alkylating capability.
      X B Kong, L Rubin, L I Chen, G Ciszewska, K A Watanabe, W P Tong, F M Sirotnak and T C Chou
      Molecular Pharmacology February 1992, 41 (2) 237-244;

S

  1. Saavedra, J M

    1. Heterogeneity of angiotensin II AT2 receptors in the rat brain.
      K Tsutsumi and J M Saavedra
      Molecular Pharmacology February 1992, 41 (2) 290-297;

  2. Sarau, H M

    1. Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C.
      T L Yue, J M Stadel, H M Sarau, E Friedman, J L Gu, D A Powers, M M Gleason, G Feuerstein and H Y Wang
      Molecular Pharmacology February 1992, 41 (2) 281-289;

  3. Schiller, C

    1. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
      R Hyland, A Gescher, K Thummel, C Schiller, P Jheeta, K Mynett, A W Smith and J Mráz
      Molecular Pharmacology February 1992, 41 (2) 259-266;

  4. Schwenner, E

    1. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties.
      H G Knaus, J Striessnig, S Hering, S Marrer, E Schwenner, H D Höltje and H Glossmann
      Molecular Pharmacology February 1992, 41 (2) 298-307;

  5. Seamon, K B

    1. Interaction of aminoalkylcarbamates of forskolin with adenylyl cyclase: synthesis of an iodinated derivative of forskolin with high affinity for adenylyl cyclase.
      A Laurenza, J D Robbins and K B Seamon
      Molecular Pharmacology February 1992, 41 (2) 360-368;

  6. Secrist, J A

    1. Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virus.
      W B Parker, S C Shaddix, P W Allan, G Arnett, L M Rose, W M Shannon, Y F Shealy, J A Montgomery, J A Secrist and L L Bennett
      Molecular Pharmacology February 1992, 41 (2) 245-251;

  7. Seguin, J

    1. Serotonin increases calcium current in human atrial myocytes via the newly described 5-hydroxytryptamine4 receptors.
      H Ouadid, J Seguin, A Dumuis, J Bockaert and J Nargeot
      Molecular Pharmacology February 1992, 41 (2) 346-351;

  8. Shaddix, S C

    1. Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virus.
      W B Parker, S C Shaddix, P W Allan, G Arnett, L M Rose, W M Shannon, Y F Shealy, J A Montgomery, J A Secrist and L L Bennett
      Molecular Pharmacology February 1992, 41 (2) 245-251;

  9. Shajenko, L

    1. Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
      R P Mason, D M Moisey and L Shajenko
      Molecular Pharmacology February 1992, 41 (2) 315-321;

  10. Shannon, W M

    1. Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virus.
      W B Parker, S C Shaddix, P W Allan, G Arnett, L M Rose, W M Shannon, Y F Shealy, J A Montgomery, J A Secrist and L L Bennett
      Molecular Pharmacology February 1992, 41 (2) 245-251;

  11. Shealy, Y F

    1. Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virus.
      W B Parker, S C Shaddix, P W Allan, G Arnett, L M Rose, W M Shannon, Y F Shealy, J A Montgomery, J A Secrist and L L Bennett
      Molecular Pharmacology February 1992, 41 (2) 245-251;

  12. Sirotnak, F M

    1. Topoisomerase II-mediated DNA cleavage activity and irreversibility of cleavable complex formation induced by DNA intercalator with alkylating capability.
      X B Kong, L Rubin, L I Chen, G Ciszewska, K A Watanabe, W P Tong, F M Sirotnak and T C Chou
      Molecular Pharmacology February 1992, 41 (2) 237-244;

  13. Smith, A W

    1. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
      R Hyland, A Gescher, K Thummel, C Schiller, P Jheeta, K Mynett, A W Smith and J Mráz
      Molecular Pharmacology February 1992, 41 (2) 259-266;

  14. Snyders, J

    1. Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel.
      J Snyders, K M Knoth, S L Roberds and M M Tamkun
      Molecular Pharmacology February 1992, 41 (2) 322-330;

  15. Sommadossi, J P

    1. Comparative effects of 3'-azido-3'-deoxythymidine and its metabolite 3'-amino-3'-deoxythymidine on hemoglobin synthesis in K-562 human leukemia cells.
      D A Weidner, E G Bridges, E M Cretton and J P Sommadossi
      Molecular Pharmacology February 1992, 41 (2) 252-258;

  16. Stadel, J M

    1. Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C.
      T L Yue, J M Stadel, H M Sarau, E Friedman, J L Gu, D A Powers, M M Gleason, G Feuerstein and H Y Wang
      Molecular Pharmacology February 1992, 41 (2) 281-289;

  17. Storm, C

    1. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
      W Y Gao, F S Han, C Storm, W Egan and Y C Cheng
      Molecular Pharmacology February 1992, 41 (2) 223-229;

  18. Striessnig, J

    1. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties.
      H G Knaus, J Striessnig, S Hering, S Marrer, E Schwenner, H D Höltje and H Glossmann
      Molecular Pharmacology February 1992, 41 (2) 298-307;

T

  1. Tamkun, M M

    1. Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel.
      J Snyders, K M Knoth, S L Roberds and M M Tamkun
      Molecular Pharmacology February 1992, 41 (2) 322-330;

  2. Thummel, K

    1. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
      R Hyland, A Gescher, K Thummel, C Schiller, P Jheeta, K Mynett, A W Smith and J Mráz
      Molecular Pharmacology February 1992, 41 (2) 259-266;

  3. Tong, W P

    1. Topoisomerase II-mediated DNA cleavage activity and irreversibility of cleavable complex formation induced by DNA intercalator with alkylating capability.
      X B Kong, L Rubin, L I Chen, G Ciszewska, K A Watanabe, W P Tong, F M Sirotnak and T C Chou
      Molecular Pharmacology February 1992, 41 (2) 237-244;

  4. Townsend, A J

    1. Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents.
      A J Townsend, C P Tu and K H Cowan
      Molecular Pharmacology February 1992, 41 (2) 230-236;

  5. Trent, R D

    1. Stimulation of N-methyl-D-aspartate receptor-mediated calcium entry into dissociated neurons by reduced and oxidized glutathione.
      S W Leslie, L M Brown, R D Trent, Y H Lee, J L Morris, T W Jones, P K Randall, S S Lau and T J Monks
      Molecular Pharmacology February 1992, 41 (2) 308-314;

  6. Tsutsumi, K

    1. Heterogeneity of angiotensin II AT2 receptors in the rat brain.
      K Tsutsumi and J M Saavedra
      Molecular Pharmacology February 1992, 41 (2) 290-297;

  7. Tu, C P

    1. Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents.
      A J Townsend, C P Tu and K H Cowan
      Molecular Pharmacology February 1992, 41 (2) 230-236;

U

  1. Ulrich, R G

    1. Enhancement of adipocyte differentiation by an insulin-sensitizing agent.
      R F Kletzien, S D Clarke and R G Ulrich
      Molecular Pharmacology February 1992, 41 (2) 393-398;

V

  1. Valenzuela, C F

    1. Modulation of phencyclidine-sensitive ethidium binding to the Torpedo acetylcholine receptor: interaction of noncompetitive inhibitors with carbamylcholine and cobra alpha-toxin.
      C F Valenzuela, J A Kerr, P Duvvuri and D A Johnson
      Molecular Pharmacology February 1992, 41 (2) 331-336;

  2. Van Berkel, T J

    1. Lactosylated high density lipoprotein: a potential carrier for the site-specific delivery of drugs to parenchymal liver cells.
      M K Bijsterbosch and T J Van Berkel
      Molecular Pharmacology February 1992, 41 (2) 404-411;

  3. Vaz, A D

    1. Role of isozymes of rabbit microsomal cytochrome P-450 in the metabolism of retinoic acid, retinol, and retinal.
      E S Roberts, A D Vaz and M J Coon
      Molecular Pharmacology February 1992, 41 (2) 427-433;

  4. Vickers, P J

    1. 5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors.
      J A Mancini, P Prasit, M G Coppolino, P Charleson, S Leger, J F Evans, J W Gillard and P J Vickers
      Molecular Pharmacology February 1992, 41 (2) 267-272;

W

  1. Wang, H Y

    1. Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C.
      T L Yue, J M Stadel, H M Sarau, E Friedman, J L Gu, D A Powers, M M Gleason, G Feuerstein and H Y Wang
      Molecular Pharmacology February 1992, 41 (2) 281-289;

  2. Ward, N E

    1. Kinetic analysis of protein kinase C inhibition by staurosporine: evidence that inhibition entails inhibitor binding at a conserved region of the catalytic domain but not competition with substrates.
      N E Ward and C A O'Brian
      Molecular Pharmacology February 1992, 41 (2) 387-392;

  3. Warner, T D

    1. Characterization of endothelin-converting enzyme from endothelial cells and rat brain: detection of the formation of biologically active endothelin-1 by rapid bioassay.
      T D Warner, J A Mitchell, P D'Orleans-Juste, K Ishii, U Förstermann and F Murad
      Molecular Pharmacology February 1992, 41 (2) 399-403;

  4. Watanabe, K A

    1. Topoisomerase II-mediated DNA cleavage activity and irreversibility of cleavable complex formation induced by DNA intercalator with alkylating capability.
      X B Kong, L Rubin, L I Chen, G Ciszewska, K A Watanabe, W P Tong, F M Sirotnak and T C Chou
      Molecular Pharmacology February 1992, 41 (2) 237-244;

  5. Weidner, D A

    1. Comparative effects of 3'-azido-3'-deoxythymidine and its metabolite 3'-amino-3'-deoxythymidine on hemoglobin synthesis in K-562 human leukemia cells.
      D A Weidner, E G Bridges, E M Cretton and J P Sommadossi
      Molecular Pharmacology February 1992, 41 (2) 252-258;

  6. Werner, M H

    1. Quantitative analysis of diacylglycerol second messengers in human platelets: correlation with aggregation and secretion.
      M H Werner, A E Bielawska and Y A Hannun
      Molecular Pharmacology February 1992, 41 (2) 382-386;

  7. Wess, J

    1. Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors.
      J Wess, D Gdula and M R Brann
      Molecular Pharmacology February 1992, 41 (2) 369-374;

Y

  1. Yue, T L

    1. Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C.
      T L Yue, J M Stadel, H M Sarau, E Friedman, J L Gu, D A Powers, M M Gleason, G Feuerstein and H Y Wang
      Molecular Pharmacology February 1992, 41 (2) 281-289;

Z

  1. Zumbihl, R

    1. Specific antibodies against Go isoforms reveal the early expression of the Go2 alpha subunit and appearance of Go1 alpha during neuronal differentiation.
      B Rouot, N Charpentier, C Chabbert, J Carrette, R Zumbihl, J Bockaert and V Homburger
      Molecular Pharmacology February 1992, 41 (2) 273-280;
Back to top

In this issue

Advertisement